淋巴瘤异常表达:诊断陷阱综述
本文综述成熟淋巴瘤中谱系相关抗原异常获得表达的情况,指出免疫组化或流式细胞术检测的谱系特异性标记可出现异常获得或丢失,淋巴瘤也可异常表达非造血标记,并给出避免诊断陷阱、实现准确诊断的建议。
要点
- 淋巴瘤可异常获得谱系相关抗原表达,造成谱系误判。
- 淋巴瘤可异常表达非造血标记,反之亦然。
- 需警惕异常表达并遵循建议以避免诊断陷阱。
核心结论
- 成熟淋巴瘤中谱系相关抗原的异常获得表达是实际血液病理诊断的主要难点之一,可导致分类困难。
研究设计与样本
- 综述文章,概述成熟淋巴瘤中谱系相关抗原异常获得表达的情况。
主要发现
- 谱系特异性标记通过免疫组化或流式细胞术免疫表型方法检测,日常实践中偶尔遇到异常获得或丢失。
- 淋巴瘤可异常表达非造血标记,非造血肿瘤也可异常表达造血标记。
临床怎么用
- 文中提供避免诊断陷阱的建议,以最终达到准确诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One of the major difficulties in practical hematopathology is to accurately assign cell lineage and thus ensure proper classification of lymphomas. The lineage-specific markers of lymphoma are detected by immunohistochemistry or flow cytometry immunophenotypic methods. However, aberrant gain or loss of these markers is occasionally encountered during daily practice, which often creates diagnostic challenges. In addition, lymphoma may aberrantly express non-hematopoietic markers, and vice versa. This review article provides an overview of aberrant gain of expression of lineage-associated antigens in mature lymphoid neoplasms, including recommendations to avoid diagnostic pitfalls and ultimately to reach accurate diagnoses.
引用
- Song JY, Pan Z. Aberrant expression in lymphoma, a diagnostic pitfall. Hum Pathol. 2024. PMID: 39674282. doi:10.1016/j.humpath.2024.105706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。